Atorvastatin Calcium
Product Images NDC 68071-2755

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2755). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2755 09)

Label for Atorvastatin Calcium 40mg tablets, manufactured by Sun Pharmaceutical Industries Limited, Moball, India, and packaged by NuCare Pharmaceuticals, Inc., Orange, CA. The label indicates a package size of 90 tablets, prescription only (Rx only), with storage instructions to keep at controlled temperature 68-77°F. Includes warnings to keep out of reach of children and a note to see the manufacturer's label for a full list of ingredients.*

FDA Label Image

Structure (Image 01)

Chemical structure of Atorvastatin Calcium showing the molecular arrangement including phenyl groups, hydroxyl groups, and calcium ion complexation with water molecules, consistent with the active ingredient Atorvastatin Calcium.*

FDA Label Image

Figure1 (Image 02)

A cumulative incidence graph comparing Atorvastatin to placebo over 3.5 years, showing the percentage incidence on the vertical axis and time in years on the horizontal axis. Atorvastatin's curve lies below placebo, indicating lower incidence, with a hazard ratio (HR) of 0.64 and p=0.0005 noted on the chart.*

FDA Label Image

Figure 2 (Image 03)

A line chart showing cumulative hazard (%) over time (years) for Atorvastatin versus placebo. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis represents cumulative hazard percentage. The chart compares risk trends between Atorvastatin (solid line) and placebo (dashed line).*

FDA Label Image

Figure 3 (Image 04)

A line graph comparing the percentage of subjects experiencing a cardiovascular event over five years for Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis shows time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects. The graph includes a hazard ratio (HR) of 0.78 with confidence intervals and a p-value indicating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.